A Method to Monitor the NAD + Metabolome-From Mechanistic to Clinical Applications

Nicotinamide adenine dinucleotide (NAD ) and its reduced form (NADH) are coenzymes employed in hundreds of metabolic reactions. NAD also serves as a substrate for enzymes such as sirtuins, poly(ADP-ribose) polymerases (PARPs) and ADP-ribosyl cyclases. Given the pivotal role of NAD(H) in health and d...

Full description

Saved in:
Bibliographic Details
Published inInternational journal of molecular sciences Vol. 22; no. 19; p. 10598
Main Authors Giner, Maria Pilar, Christen, Stefan, Bartova, Simona, Makarov, Mikhail V, Migaud, Marie E, Canto, Carles, Moco, Sofia
Format Journal Article
LanguageEnglish
Published Switzerland MDPI AG 30.09.2021
MDPI
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Nicotinamide adenine dinucleotide (NAD ) and its reduced form (NADH) are coenzymes employed in hundreds of metabolic reactions. NAD also serves as a substrate for enzymes such as sirtuins, poly(ADP-ribose) polymerases (PARPs) and ADP-ribosyl cyclases. Given the pivotal role of NAD(H) in health and disease, studying NAD metabolism has become essential to monitor genetic- and/or drug-induced perturbations related to metabolic status and diseases (such as ageing, cancer or obesity), and its possible therapies. Here, we present a strategy based on liquid chromatography-tandem mass spectrometry (LC-MS/MS), for the analysis of the NAD metabolome in biological samples. In this method, hydrophilic interaction chromatography (HILIC) was used to separate a total of 18 metabolites belonging to pathways leading to NAD biosynthesis, including precursors, intermediates and catabolites. As redox cofactors are known for their instability, a sample preparation procedure was developed to handle a variety of biological matrices: cell models, rodent tissues and biofluids, as well as human biofluids (urine, plasma, serum, whole blood). For clinical applications, quantitative LC-MS/MS for a subset of metabolites was demonstrated for the analysis of the human whole blood of nine volunteers. Using this developed workflow, our methodology allows studying NAD biology from mechanistic to clinical applications.
ISSN:1422-0067
1661-6596
1422-0067
DOI:10.3390/ijms221910598